Meet Ava

Ava is a digital women’s health company with offices in Zurich, San Francisco, Makati and Belgrade. Ava’s mission is to advance women’s reproductive health by bringing together artificial intelligence and clinical research.

Ava aims to be a long-term companion for women, providing data-driven and scientifically proven insights along all stages of their reproductive lives.

The Ava Bracelet

The Ava bracelet was launched in the US in July 2016, and is now sold worldwide. Worn only during sleep, it provides women with real time, personalized information about fertility, pregnancy, and general health—delivered in a way that is convenient and non-invasive.

Ava published a peer-reviewed clinical paper in the Journal of Medical Internet Research which demonstrated changes in 5 physiological signals during the menstrual cycle*. The study found that by tracking these 5 signals simultaneously, Ava can detect 5 fertile days in real-time. No other CE-marked medical device tracks all 5 of these signals.

Milestones in Ava’s History


Feb '21

Ava Fertility Tracker receives a CE mark according to EU MDR

Jan '21

Ava becomes the first and only wearable fertility tracker to receive FDA clearance

50,000 pregnancies

Nov '20

Partnership with Aristo Pharma in Germany

Jun '20

Partnership with Carrot employer fertility benefits in the US

Mar '20

Launch of clinical trial into the Ava bracelet’s pre-symptomatic detection of COVID-19

Jan '20

Lea von Bidder moves into CEO role

Dec '19

30’000 pregnancies

Aug '19

Successful registration of 4 new patents

Apr '19

Publication of Peer Reviewed Clinical Paper in JMIR

Mar '19

20’000 pregnancies with 50 new pregnancies a day

Dec '18

A winner of the Women’s Health Femtech Award 2018

Nov '18

Launch in Canada

Oct '18

Launch of the re-designed bracelet Ava 2.0

Sep '18

1st place – Swiss Startup Award 2018

Jul '18

1,000 Ava babies born & over 10,000 pregnancies

Jun '18

1st place – Swiss Medtech Award 2018

Finalist – Swiss Economic Award 2018

May '18

Announcement of Series B round of financing amounting to USD 30 million

Feb '18

First Ava baby born in Switzerland

Jan '18

Study initiated to detect pregnancy complications

Study initiated to provide support for irregular cycles and PCOS

Sep '17

1st place – Swiss Startup Award 2017

Aug '17

First Ava baby born in the US

May '17

Editor’s Choice Award from Women’s Health magazine

Jan '17

Best of Baby Tech Award 2017

Nov '16

Announcement of round of financing amounting to USD 10 million

Sep '16

6th place – Swiss Startup Award 2016

Jul '16

The first Ava bracelet is launched in the US market

Apr '16

Results revealed of the first clinical trial conducted at the University of Zürich on behalf of Ava

Feb '16

Opening of the San Francisco office

Nov '15

Swiss companies such as Zürcher Kantonalbank and Swisscom invest USD 2.6 million in Ava

Sep '15

First top 100 position in the Swiss Startup Award

Sep '14

Founding of company (Ava AG in Switzerland and Ava Science in the US)


Meet the people behind Ava

Ava was founded in Switzerland in 2014 by Pascal Koenig, Philipp Tholen, Peter Stein, and Lea von Bidder.
The people behind Ava share a commitment to supporting research and advancement in women’s health technology.
  • Lea Von Bidder
    Lea Von Bidder Co-Founder & CEO
  • Pascal Koenig
    Pascal Koenig Co-founder & Member of the board
  • Stephen La Barbera
    Stephen La Barbera VP Marketing
  • Dr. Maureen Cronin
    Dr. Maureen Cronin Chief medical officer
  • Sandra Erismann
    Sandra Erismann Chief Financial Officer
  • Naemi Benz
    Naemi Benz VP Operations

Get in touch

Ava AG
Global Headquarters
Gutstrasse 73 | 8055 Zürich
Ava Science Inc.
U.S Office
77 Geary Street – 5th Floor | San Francisco, CA 94108
United States
By continuing to use the site, you agree to the use of cookies. More information Accept

This site is using first and third party cookies to be able to adapt the advertising based on your preferences. If you want to know more or modify your settings, click here. By continuing to use the site, you agree to the use of cookies.